A recent clinical trial investigating the effects of vitamin D and probiotic co-supplementation on migraines yielded positive results among 72 participants aged 18 to 55 diagnosed with migraines. Those receiving vitamin D (50,000 IU biweekly) and probiotics (4.5\u2009\u00d7\u200910\u00b9\u00b9 CFU daily) experienced a significant increase in serum vitamin D levels, averaging a rise of 12.86 ng\/mL compared to just 1.12 ng\/mL in the placebo group. Participants taking the co-supplement also showed a notable reduction in migraine frequency, with an average decrease of 3.17 headaches per month versus 1.25 in the placebo group, along with a significant reduction in migraine severity. However, the study did not find significant changes in headache duration or improvements in high-sensitivity C-reactive protein (hs-CRP) levels, nor in mental health scores measured by the HIT-6 and DASS questionnaires. These findings suggest that vitamin D and probiotic co-supplementation may offer a promising approach for managing migraines, highlighting the need for further investigation to confirm these benefits.<\/p>\n\n\n\n